Welcome to the INA-RESPOND public website.
Current and expanding infectious disease profile in Indonesia warrants a sense of urgency and mandates that research be a priority to guide the management and prevention of disease to reduce morbidity and mortality. The purpose of Indonesia Research Partnership on Infectious Diseases (INA-RESPOND) is to bring together clinical and academic medical institutions to develop a robust collaborative infectious disease research network.
About INA-RESPOND: The Indonesian Research Partnership on Infectious Disease (INA-RESPOND) stands at the forefront of infectious disease research. Our esteemed network comprises professionals driven to make meaningful contributions to the global understanding of communicable diseases. We promote innovative solutions and approaches in the battle against infectious diseases by forging cooperation with premier universities and researchers
By: Aly Diana The Thylacine, scientifically known as Thylacinus cyno-cephalus or the Tasmanian Tiger, was an extraordinary carnivorous marsupial and the sole member of the Thy-lacinidae family to survive into modern times. Historical-ly, the Thylacine was widespread across Australia, but its presence on the mainland ceased around 3,000 years ago. Roughly 14,000 years ago, changes
By: Dedy Hidayat In the dynamics of an office environment, where a diverse group of individuals works towards common goals, the essence of collaboration becomes increasingly significant. It forms an intricate web that interconnects everyone, setting the foundation for an effective, efficient, and harmonious workplace. The Importance of Collaboration The process of working together to
By: Louis Grue, Mila Erastuti, Tiya Saraswati, Virtania Meirina Agusta Anyone who has been involved in conducting INA-RESPOND’s studies might be familiar with the term “Note to File (NTF)” and might have had experience in generating this document. The INA-RESPOND Good Documentation Practices SOP states that a NTF could be utilized and may be useful
To collect standardized baseline and longitudinal data describing the course of HIV disease in antiretroviral-naive and treatment-experienced individuals to inform policy.
Implementing a Combination of Clinical Parameters (Rapid Diagnostic Tests, Biomarkers and Standard of Care Procedures) for the Etiology Diagnosis of Pneumonia in Paediatric Patients to Improve Clinical Management in Indonesia
To identify COVID-19 and other respiratory infectious disease cases from hospitalized suspected COVID-19 patients.
to compare the virological efficacy of the three regimens in the intention to treat (ITT) population. Virological efficacy is defined as the proportion of participants with plasma HIV RNA (pVL) <50 copies/mL at 48 weeks.
Among participants testing positive for SARS-CoV-2: Estimate the rate of hospitalization or death during the 28 day follow-up period. Identify risk factors for hospitalization or death.
Primary Objective: The primary endpoint of this trial in hospitalized patients is an ordinal outcome based on the patient’s clinical status on Day 7. It includes seven mutually exclusive categories capturing the range of organ dysfunction that may be associated with the progression of COVID-19, such as respiratory dysfunction and coagulation-related complications.
To characterize immunogenicity (by measurement of anti-S Ab) of available COVID-19 vaccine regimens in people who received an initial vaccine or booster regimen, in each of the countries at 2 months after completion of the initial full vaccine regimen or booster vaccine regimen.
To identify the etiology of acute febrile illness cases and evaluate clinical manifestations and outcomes.
To determine the causes of community-acquired sepsis and severe sepsis in adults and pediatrics across Southeast Asia.
To estimate the proportion of MDR TB amongst treatment naïve new treatment naïve and previously treated cases.
